NASDAQ:NOVT - Novanta Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$68.54 +1.33 (+1.98 %)
(As of 01/17/2019 04:00 PM ET)
Previous Close$67.21
Today's Range$66.11 - $69.03
52-Week Range$48.40 - $78.85
Volume90,100 shs
Average Volume144,617 shs
Market Capitalization$2.36 billion
P/E Ratio42.84
Dividend YieldN/A
Beta1.55
Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products for photonics-based applications, such as industrial material processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. Its Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; surgical displays and operating room integration technologies; optical data collection and machine vision technologies; radio frequency identification technologies; thermal printers; spectrometry technologies; and embedded touch screen solutions. The company's Precision Motion segment offers optical encoders, precision motor and motion control technology, air bearing spindles, and precision machined components. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Lincoln Laser, ExoTec Precision, Synrad, Laser Quantum, WOM, Lemke, NDS, NDSsi, Reach Technology, JADAK, Skyetek, ThingMagic, Photo Research, General Scanning, Celera Motion, MicroE, Applimotion, and Westwind brands. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.

Receive NOVT News and Ratings via Email

Sign-up to receive the latest news and ratings for NOVT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous electrical machinery, equipment, & supplies
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:NOVT
Previous SymbolNASDAQ:GSIG
CUSIPN/A
Phone781-266-5700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$521.29 million
Cash Flow$2.5603 per share
Book Value$9.01 per share

Profitability

Net Income$60.05 million

Miscellaneous

Employees2,034
Market Cap$2.36 billion
OptionableOptionable

Novanta (NASDAQ:NOVT) Frequently Asked Questions

What is Novanta's stock symbol?

Novanta trades on the NASDAQ under the ticker symbol "NOVT."

How were Novanta's earnings last quarter?

Novanta Inc (NASDAQ:NOVT) released its quarterly earnings results on Tuesday, November, 6th. The technology company reported $0.61 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.52 by $0.09. The technology company earned $160.79 million during the quarter, compared to analysts' expectations of $154.43 million. Novanta had a net margin of 6.18% and a return on equity of 18.95%. The business's quarterly revenue was up 9.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.45 earnings per share. View Novanta's Earnings History.

When is Novanta's next earnings date?

Novanta is scheduled to release their next quarterly earnings announcement on Wednesday, February 27th 2019. View Earnings Estimates for Novanta.

What guidance has Novanta issued on next quarter's earnings?

Novanta updated its FY18 earnings guidance on Tuesday, November, 6th. The company provided EPS guidance of $2.07-2.12 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.00. The company issued revenue guidance of $610-614 million, compared to the consensus revenue estimate of $605.10 million.

What price target have analysts set for NOVT?

2 brokers have issued 1-year price objectives for Novanta's shares. Their predictions range from $54.00 to $54.00. On average, they expect Novanta's share price to reach $54.00 in the next twelve months. This suggests that the stock has a possible downside of 21.2%. View Analyst Price Targets for Novanta.

What is the consensus analysts' recommendation for Novanta?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Novanta in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Novanta.

Has Novanta been receiving favorable news coverage?

Media headlines about NOVT stock have trended negative recently, according to InfoTrie. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Novanta earned a news impact score of -2.8 on InfoTrie's scale. They also assigned news coverage about the technology company a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an effect on the stock's share price in the near future.

Who are some of Novanta's key competitors?

Who are Novanta's key executives?

Novanta's management team includes the folowing people:
  • Mr. Matthijs Glastra, CEO & Director (Age 49)
  • Mr. Robert J. Buckley, Chief Financial Officer (Age 44)
  • Mr. Brian S. Young, Chief HR Officer (Age 49)
  • Mr. Peter L. Chang, VP, Corp. Controller & Chief Accounting Officer (Age 53)
  • Mr. Heinrich Dreyer, Group Pres of Minimally Invasive Surgery

Who are Novanta's major shareholders?

Novanta's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Anderson Hoagland & Co. (0.07%), Navellier & Associates Inc (0.06%), KAMES CAPITAL plc (0.05%) and Juncture Wealth Strategies LLC (0.02%). Company insiders that own Novanta stock include Matthijs Glastra, Peter L Chang, Robert Buckley and Stephen W Bershad. View Institutional Ownership Trends for Novanta.

Which major investors are selling Novanta stock?

NOVT stock was sold by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc, Anderson Hoagland & Co. and Navellier & Associates Inc. Company insiders that have sold Novanta company stock in the last year include Matthijs Glastra, Peter L Chang, Robert Buckley and Stephen W Bershad. View Insider Buying and Selling for Novanta.

Which major investors are buying Novanta stock?

NOVT stock was bought by a variety of institutional investors in the last quarter, including Juncture Wealth Strategies LLC. View Insider Buying and Selling for Novanta.

How do I buy shares of Novanta?

Shares of NOVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Novanta's stock price today?

One share of NOVT stock can currently be purchased for approximately $68.54.

How big of a company is Novanta?

Novanta has a market capitalization of $2.36 billion and generates $521.29 million in revenue each year. The technology company earns $60.05 million in net income (profit) each year or $1.60 on an earnings per share basis. Novanta employs 2,034 workers across the globe.

What is Novanta's official website?

The official website for Novanta is http://www.novanta.com.

How can I contact Novanta?

Novanta's mailing address is 125 Middlesex Turnpike, Bedford MA, 01730. The technology company can be reached via phone at 781-266-5700 or via email at [email protected]


MarketBeat Community Rating for Novanta (NASDAQ NOVT)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  154 (Vote Outperform)
Underperform Votes:  128 (Vote Underperform)
Total Votes:  282
MarketBeat's community ratings are surveys of what our community members think about Novanta and other stocks. Vote "Outperform" if you believe NOVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NOVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2019 by MarketBeat.com Staff

Featured Article: Debt-To-Equity Ratio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel